Llwytho...
Serum-binding properties of isosteric ruthenium and osmium anticancer agents elucidated by SEC–ICP–MS
ABSTRACT: Size-exclusion chromatography–inductively coupled plasma–mass spectrometry (SEC–ICP–MS) was used to study the serum-binding preferences of two metallodrugs with anticancer activities in vivo, namely the organoruthenium compound plecstatin-1 and its isosteric osmium analog. The complexes we...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Monatsh Chem |
|---|---|
| Prif Awduron: | , , , , , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Springer Vienna
2018
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6133104/ https://ncbi.nlm.nih.gov/pubmed/30237619 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00706-018-2280-1 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|